"Maine Medical Partners – Neurology has moved and is now located at 92 Campus Drive in Scarborough, ME"

During the past decade, Maine Medical Partners Neurology conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 7 clinical trials were completed, i.e. on average, 63.6% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 4 clinical trials were completed. i.e. 80% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Maine Medical Partners Neurology" #1 sponsor was "Eli Lilly and Company" with 3 trials, followed by "JANSSEN Alzheimer Immunotherapy Research & Development, LLC" with 3 trials sponsored, "Epix Pharmaceuticals, Inc." with 2 trials sponsored, "Hoffmann-La Roche" with 2 trials sponsored and "National Cancer Institute (NCI)" with 2 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Maine Medical Partners Neurology" #1 collaborator was "Pfizer" with 3 trials as a collaborator, "Canadian Cancer Trials Group" with 1 trials as a collaborator, "Elan Pharmaceuticals" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator and "European Organisation for Research and Treatment Center (EORTC)" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Maine Medical Partners Neurology" are "Alzheimer's Disease" (10 trials), "Acute Myeloid Leukemia" (1 trials), "Brain and Central Nervous System Tumors" (1 trials), "Clinical Stage III Cutaneous Melanoma AJCC v8" (1 trials) and "Clinical Stage IV Cutaneous Melanoma AJCC v8" (1 trials). Many other conditions were trialed in "Maine Medical Partners Neurology" in a lesser frequency.

Most popular intervention types in "Maine Medical Partners Neurology" are "Drug" (20 trials), "Other" (2 trials), "Procedure" (2 trials), "Radiation" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "Bapineuzumab 0.5 mg/kg" (2 trials), "Bapineuzumab 1.0 m/kg" (2 trials), "Crenezumab" (2 trials) and "PRX-03140" (2 trials). Other intervention names were less common.

The vast majority of trials in "Maine Medical Partners Neurology" are 21 trials for "All" genders.

Currently, there are NaN active trials in "Maine Medical Partners Neurology". undefined are not yet recruiting, 2 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Maine Medical Partners Neurology, undefined suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in Maine Medical Partners Neurology, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".